Jan 24, 2025 | Arbitration, Blog Post, Private Equity
Before the passage of the No Surprises Act, too many patients experienced the costly burden of surprise medical bills. President Trump signed this landmark law in December 2020, and since it took effect in January 2022, it is preventing approximately 1 million...
Nov 19, 2024 | Arbitration, Blog Post, Private Equity
Certain private equity-backed providers are flooding the federal arbitration process with thousands of frivolous and ineligible claims, according to a new analysis from Brookings Institution researchers published in Health Affairs. The latest assessment confirms that...
Nov 13, 2024 | Arbitration, Blog Post, Private Equity
While the No Surprises Act took a critical step in banning unfair, egregious surprise medical bills, certain private equity-backed providers continue to abuse and misuse the law’s arbitration process (also known as independent dispute resolution, or IDR) as a “back...
Oct 16, 2024 | Arbitration, Blog Post, Private Equity
Prior to the passage of the No Surprises Act, certain private equity-backed health care providers designed an entire business model around strategically exiting health plans’ networks as a way to maximize out-of-network reimbursements at the expense of patients,...
Sep 13, 2024 | Arbitration, Blog Post, Private Equity
Researchers at Georgetown University’s Center on Health Insurance Reform recently analyzed new data from the Centers for Medicare & Medicaid Services (CMS) detailing arbitration outcomes from all of 2023 under the No Surprises Act. While the law has been effective...
Aug 27, 2024 | Arbitration, Blog Post, Private Equity
Researchers from the Brookings Institution recently analyzed the latest data from the Centers for Medicare & Medicaid Services (CMS) detailing arbitration outcomes under the No Surprises Act (NSA). The analysis reviews Q3 and Q4 2024 outcomes as an update to their...
Recent Comments